4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-21-055543
Director sold 18,279 shares at an average $16.01 ($292,670)
- Director acquired 18,279 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
CHESS ROBERT · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-08 | Exercise or conversion : show line 1 in the form | +8,000 | $13.80 | $110,400 | 282,273 | D |
| 2021-09-08 | Sale : show line 2 in the form | −8,000 | $16.00 | $128,000 | 274,273 | D |
| 2021-09-09 | Exercise or conversion : show line 3 in the form | +10,279 | $13.80 | $141,850 | 284,552 | D |
| 2021-09-09 | Sale : show line 4 in the form | −10,279 | $16.02 | $164,670 | 274,273 | D |
| Open-market sales · 18,279 sh · avg $16.01 · $292,670 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-08 | Exercise or conversion : show line 5 in the form Common Stock | −8,000 | 10,279 | D |
| 2021-09-09 | Exercise or conversion : show line 6 in the form Common Stock | −10,279 | 0 | D |
Loading xslF345X03/doc4.xml…